1Robert J. Prostate cancer:Current and evolving strategies. Am J Health - Syst Pharm, 1996,53(4) :381 ～ 396
2Martindale. The Extra Pharmacopoeia 31ed London:The Royal Pharmaceufical Society, 1996. 575
3Cusan L,et al. Comparison of flutamide and spironolactone in the treatment of hirsufism:a randomized controlled trial. Fertil Steril,1994,61:281 ～ 287
4Pucci E,et al. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome. Gynecol Endocrinol,1995,9(3) :221 ～ 228
5Dodin S,et al. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsufism. Can - clin Endocrinol, 1995,43 (5): 575 ～ 582
6Martindale. The Extra Pharmacopoeia 28ed London:The Royal Pharmaceutical Society,1982. 1414
7BergmanL.ActaPsychiatrScand,1996,94(2):137-139
8Wysowski DK,et al. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med, 1993,118: 860 ～ 864
9FDA. Nilutamide approved for metastatic prostate cancer. Am J HealthSyst Pharm,1996,53(23):2784
10Alexander W. Prostate cancer treatments generate mixed reviews. Drug Store News for Pharm,1996,6:63
